Acceptability of Uncoated Mini-Tablets in Neonates—A Randomized Controlled Trial

Journal of Pediatrics

Volumn 167, Issue 4, 2015, Pages 893-896.e2

  Klingmann, Viviane ^a   Seitz, Annika ^a   Meissner, Thomas ^a   Breitkreutz, Jörg ^b   Moeltner, Andreas ^c   Bosse, Hans Martin ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Kompetenzzentrum für Prüfungen in der Medizin Baden Württemberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LACTOSE; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; PLACEBO; SILICON DIOXIDE; DRUG; TABLET;

ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG COATING; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SWALLOWING; SYRUP; TABLET FORMULATION; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; AREA UNDER THE CURVE; COUGHING; FEMALE; MALE; ORAL DRUG ADMINISTRATION; REPRODUCIBILITY; TABLET;

ADMINISTRATION, ORAL; AREA UNDER CURVE; COUGH; CROSS-OVER STUDIES; DEGLUTITION; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TABLETS;

EID: 84938779294     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.07.010     Document Type: Article

References (13)

1. 1 European Medicines Agency (EMA). Report on the survey of all paediatric uses of medicinal products in Europe. EMA/794083/2009, 2010, European Medicines Agency, London http://www.ema.europa.eu. Accessed August 4, 2015.
2. 2 Sixtieth World Health Assembly. WHA60.20. Better medicines for children. Eleventh plenary meeting, Agenda item 12.18 of 23 May 2007. World Health Organization 2007.
3. 3 World Health Organization. WHO campaigns: make medicines child size. Finney E. Children's medicines: a situational analysis. 2011, World Health Organization http://www.who.int/childmedicines/progress/CM_analysis.pdf. Accessed August 4, 2015.
4. 4 Ivanovska, V., Rademaker, C.M., van Dijk, L., Mantel-Teeuwisse, A.K., Pediatric drug formulations: a review of challenges and progress. Pediatrics 134 (2014), 361–372.
5. 5 European Medicines Agency (EMA). Committee for Medicinal products for Human use (CHMP). Reflection Paper: Formulations of Choice for the Paediatric Population. EMEA/CHMP/PEG/194810/2005, 2006, European Medicines Agency, London www.ema.europa.eu. Accessed August 4, 2015.
6. 6 Yeung, V.W., Wong, I.C., When do children convert from liquid antiretroviral to solid formulations?. Pharm World Sci 27 (2005), 399–402.
7. 7 Breitkreutz, J., Wessel, T., Boos, J., Dosage forms for peroral administration to children. Paediatr Perinat Drug Ther 3 (1999), 25–33.
8. 8 Allegaert, K., Anderson, B.J., Vrancken, M., Debeer, A., Desmet, K., Cosaert, K., et al. Impact of a paediatric vial on the magnitude of systematic medication errors in neonates. Paediatr Perinat Drug Ther 7 (2006), 59–63.
9. 9 Spomer, N., Klingmann, V., Stoltenberg, I., Lerch, C., Meissner, T., Breitkreutz, J., Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study. Arch Dis Child 97 (2012), 283–286.
10. 10 Klingmann, V., Spomer, N., Lerch, C., Stoltenberg, I., Frömke, C., Bosse, H.M., et al. Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children. J Pediatr 163 (2013), 1728–1732.
11. 11 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice E6(R1). Federal Register 62:90 (1997), 25691–25709.
12. 12 Liu, J.P., Hsueh, H.M., Hsieh, E., Chen, J.J., Tests for equivalence or non-inferiority for paired binary data. Stat Med 21 (2002), 231–245.
13. 13 Nam, J.M., Establishing equivalence of two treatments and sample size requirements in matched-pairs design. Biometrics 53 (1997), 1422–1430.